MarketCap
Facebook
X
Telegram
Assertio Holdings Current Ratio | ASRT
Annual Current Ratio Assertio Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.54 | 1.74 | 1.93 | 2.2 | 1.46 | 0.71 | 0.563 | 0.846 | 0.743 | 1.35 | 1.41 | 10.7 | 2.15 | 2.6 | 2.75 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.7 | 0.563 | 2.18 |
Quarterly Current Ratio Assertio Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.56 | 1.49 | 1.52 | 1.61 | 1.74 | 1.9 | 1.9 | 1.91 | 1.93 | 2.03 | 2.68 | 2.53 | 2.2 | 1.72 | 1.66 | 1.49 | 1.46 | 1.48 | 1.42 | 1.48 | 1.22 | 1.22 | 1.22 | 1.22 | 1.12 | 1.12 | 1.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.68 | 1.12 | 1.63 |
Current Ratio of other stocks in the Drug manufacturers industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cronos Group
CRON
|
22.1 | $ 3.26 | 0.62 % | $ 1.25 B |  Canada |
 |
Evoke Pharma
EVOK
|
1.67 | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
1.85 | - | 2.45 % | $ 38.1 M | Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
5.85 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
2.34 | - | 7.5 % | $ 6.35 M | USA |
 |
China Pharma Holdings
CPHI
|
3.75 | $ 0.84 | 1.18 % | $ 3.6 M |  China |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
0.944 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
0.961 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
0.386 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
1.43 | - | - | $ 142 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
1.82 | - | - | $ 2.06 B |  France |
 |
Athenex
ATNX
|
0.894 | - | -23.39 % | $ 1.76 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
1.47 | $ 6.75 | 3.53 % | $ 100 M | USA |
 |
Catalent
CTLT
|
1.59 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
1.95 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
2.35 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
0.916 | - | - | $ 28.9 M |  Irlanda |
 |
Rockwell Medical
RMTI
|
2.83 | $ 7.99 | 0.31 % | $ 287 M | USA |
 |
Jupiter Wellness
JUPW
|
6.86 | - | - | $ 33.6 M | USA |
 |
Evolus
EOLS
|
0.907 | $ 9.05 | 0.11 % | $ 583 M | USA |
 |
Lannett Company
LCI
|
0.659 | - | 1.15 % | $ 7.11 M | USA |
 |
Sundial Growers
SNDL
|
5.69 | $ 1.41 | 4.41 % | $ 364 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
12.2 | - | - | $ 193 M | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
5.98 | - | - | $ 55.5 M | USA |
 |
Radius Health
RDUS
|
0.418 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
1.62 | - | 1.64 % | $ 400 M | USA |
 |
Tilray
TLRY
|
3.55 | $ 4.53 | 0.22 % | $ 4.03 B | Canada |
 |
Recro Pharma
REPH
|
1.62 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
0.761 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
3.07 | - | -27.8 % | $ 2.56 M | USA |
 |
Harrow Health
HROW
|
1.15 | $ 38.26 | 5.63 % | $ 1.41 B | USA |
 |
Zomedica Corp.
ZOM
|
10.9 | - | -0.21 % | $ 98 M | USA |
 |
Tricida
TCDA
|
1 | - | - | $ 3.25 M | USA |
 |
Bausch Health Companies
BHC
|
1.01 | $ 6.76 | 5.56 % | $ 2.51 B | Canada |
 |
Emergent BioSolutions
EBS
|
1.66 | $ 6.23 | 3.86 % | $ 333 M | USA |
 |
Organogenesis Holdings
ORGO
|
3.63 | $ 1.64 | 2.45 % | $ 208 M | USA |
 |
OrganiGram Holdings
OGI
|
4 | $ 1.17 | 0.42 % | $ 111 M | Canada |
 |
Veru
VERU
|
2.59 | $ 2.65 | 2.23 % | $ 38.8 M | USA |
 |
Perrigo Company plc
PRGO
|
1.52 | $ 14.27 | 0.42 % | $ 1.98 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
1.28 | $ 1.32 | 2.33 % | $ 2.22 M | USA |
 |
Relmada Therapeutics
RLMD
|
12.5 | $ 4.37 | 1.79 % | $ 173 M | USA |
 |
SCYNEXIS
SCYX
|
6.12 | $ 5.35 | 2.39 % | $ 267 M | USA |
 |
TherapeuticsMD
TXMD
|
3.49 | $ 2.24 | 0.22 % | $ 25.9 M | USA |
 |
Solid Biosciences
SLDB
|
4.43 | $ 10.42 | 1.31 % | $ 912 M | USA |
 |
Viatris
VTRS
|
1.65 | $ 16.94 | 2.77 % | $ 19.5 B | USA |
 |
Canopy Growth Corporation
CGC
|
2.66 | $ 0.97 | 0.5 % | $ 289 M | Canada |
 |
cbdMD
YCBD
|
3.26 | $ 0.48 | 0.8 % | $ 1.93 M | USA |
 |
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | USA |
 |
Aurora Cannabis
ACB
|
3.49 | $ 3.89 | 0.74 % | $ 213 M | Canada |